Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements Sep 20, 2024
Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024 Sep 16, 2024
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference Sep 09, 2024
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference Sep 04, 2024
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference Sep 04, 2024
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference Sep 04, 2024
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights Aug 13, 2024
Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights Aug 12, 2024
Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates Aug 12, 2024
